Sat.May 14, 2022 - Fri.May 20, 2022

article thumbnail

Moderna’s HIV vaccine prepped for trials in Africa

pharmaphorum

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt. IAVI (the International AIDS Vaccine Initiative) has started screening subjects to be included in the study, called IAVI G003, at centres in Rwanda and South Africa, said the biotech.

Vaccines 145
article thumbnail

Artificial intelligence stands to transform precision medicine: AiCure

Outsourcing Pharma

An expert from the AI-focused technology company shares insights as to how it can be harnessed to better interpret, and even predict, patient behavior.

131
131
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Finding the Right Job for You as a Pharmacist

The Happy PharmD

By going through pharmacy school, you have a well-rounded background in various areas, including communication skills through delivering presentations and counseling patients, motivational interviewing experience, and some degree of technical writing experience. The curriculum is structured to make the average pharmacist an excellent communicator, a fast learner, and flexible enough to fit into different fields.

article thumbnail

Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers

Pharma Mirror

California, Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, today announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers. The new entity named “Crown Bioscience & MBL”, is a long-term strategic partnership that is expected to accelerate growth for both companies.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Google gives ex-FDA digital health head Bakul Patel strategic role

pharmaphorum

FDA veteran Bakul Patel has joined Google as its new senior director of global digital health strategy, ending a stint at the regulator that lasted more than 13 years. Bakul Patel. Patel – who is currently director for digital health at the FDA – said on social media that he is “looking forward to learning from the teams in health across Google and Alphabet and helping build a unified digital health and regulatory strategy.” He was also involved in the creation of the FDA’s Dig

FDA 139
article thumbnail

Machine learning can unlock potential of EEG data: Beacon Biosignals

Outsourcing Pharma

A leader from the neurobiomarker platform provider tells how use of ML and other advanced analytical tools can help make better use of complex information.

125
125

More Trending

article thumbnail

How to Get Out of the Pharmacist Job Search Cycle

The Happy PharmD

We have all been at various points in our lives where we felt we have had enough and desired a change. It could be breaking free from an addiction, deciding to start a family, or in this case leaving a job where you have been unhappy and stressed. However, a few days or weeks down the line, we end up not following our action plan or even fail to draft out one.

52
article thumbnail

Sleepio app for insomnia backed by NICE

pharmaphorum

After a non-committal appraisal of Big Health’s Sleepio app for insomnia last November in draft guidance from NICE, the cost-effectiveness agency has come out in favour of the digital therapy. The earlier draft guidance showed that NICE was uncertain whether Sleepio would save money for the NHS, but its latest document recommends the app as a cost-saving option for treating insomnia in primary care “for people who would otherwise be offered advice about sleep hygiene or sleeping pill

article thumbnail

NIH awards $577m to antiviral drug developers

Outsourcing Pharma

The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, has awarded a total of $577m to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

102
102
article thumbnail

Leadership Series VI: The Real Treasures are Within Us!

Colors Make me Happy

MUSC College of Pharmacy Graduation 2022 Good afternoon! Dear Faculty, families, loved ones, and GRADUATES. Thank you for inviting me to join you on this very important milestone in your life. You did it and I am proud of YOU! Congratulations. Dean Hall asked me to share with you my pharmacy journey. Instead, I would like to talk to you about the life journey of a seven-year-old refugee girl.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Chlorthalidone Versus Hydrochlorothiazide – A Comparison

Med Ed 101

Chlorthalidone and hydrochlorothiazide (podcast) are both thiazide diuretics. They are primarily used in the management of hypertension and occasionally for the management of edema. Hypokalemia, frequent urination, and risk for dehydration are all common adverse effects of both of these agents. The drug interaction profiles’ (like this one with lithium) are very similar as well. […].

45
article thumbnail

Large UK study suggests vaccination helps treat long COVID

pharmaphorum

An observational study in the UK has found evidence that COVID-19 vaccination can help alleviate the lingering symptoms that afflict some people who contract the virus, often referred to as ‘long COVID’ There have been persistent anecdotal reports that vaccines can help people with persistent symptoms get better, but the study published in the British Medical Journal is the first to explore the connection in large numbers of patients.

Vaccines 124
article thumbnail

Industry pros thankful, hopeful on Clinical Trials Day 2022

Outsourcing Pharma

Experts and organizations are honoring the occasion (designed to celebrate research accomplishments and achievements) with insights, education, and more.

98
article thumbnail

Simple blood test could save thousands from bowel cancer

Pharma Times

Comparisons with other tests available have shown that blood test has greater sensitivity for the detection of bowel cancer

51
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Nicotine Patch Clinical Pearls

Med Ed 101

Nicotine patches are a useful tool in the management of smoking cessation. The success and tolerability of this form of nicotine replacement does require some pharmacology knowledge. I lay out my most important nicotine patch clinical pearls below. Nicotine Patch Clinical Pearls – Dosing Let’s start with the dosing of nicotine patches. A clinician must […].

40
article thumbnail

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval

pharmaphorum

Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to help keep their glucose levels in check. Eli Lilly’s Mounjaro (tirzepatide) was given the green light by the US Food and Drug Administration after the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 glucagon-like peptide-1 (GLP-1 ) receptor agonist showed its effectiveness when used in conjunction with diet and exercise.

FDA 115
article thumbnail

Lilly deploys AI-powered tech to expedite drug approval process

Outsourcing Pharma

The pharmaceutical company is partnering with Yseop to install the software companyâs Augmented Analyst, designed to elevate and accelerate data analysis.

article thumbnail

Birmingham research shows promise for spinal cord injury patients

Pharma Times

Scientists demonstrated that AZD1236 halts oedema while reducing spinal cord breakdown at site of injury

49
article thumbnail

Digitize to curb staffing challenges

Pharma Manufacturing

Modern manufacturing solutions can spare pharma the worst of ongoing labor shortages

40
article thumbnail

USAID on expanding digital health globally – part one

pharmaphorum

Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), tells us what the agency focuses on to strengthen digital health infrastructure globally and improve and expand healthcare access. USAID learned a great deal from the Ebola outbreak in West Africa concerning effective digital health distribution and strategies for digital health implementation that were then applied to its COVID-19 response globally – alth

article thumbnail

Breast cancer trial patient participants younger than ever: Phesi

Outsourcing Pharma

The companyâs analysis of 2.5m patients worldwide suggest a growing proportion of younger patients, with implications for future study design and deployment.

69
article thumbnail

MHRA marketing authorisation granted for Eli Lilly’s Verzenios as early breast cancer treatment

Pharma Times

Authorisation of the treatment is based on results from the phase 3 trial

56
article thumbnail

Reevaluating pharma packaging priorities

Pharma Manufacturing

Supply chain challenges and industry trends are spurring new business strategies

article thumbnail

Coalition aims to improve cancer drug access in poorer nations

pharmaphorum

Several of the top pharmaceutical companies have joined a new coalition that aims to improve access to cancer medicines in low- and lower-middle-income countries (LLMICs). The new initiative – called ATOM (Access to Oncology Medicines) – pledges to tackle the issue that fewer than 50% of the cancer medicines on the World Health Organization’s essential medicines list are available in developing nations around the world.

article thumbnail

Closed Loop Medicine wraps DTx trial for hypertension treatment

Outsourcing Pharma

The digital therapeutics specialist has announced the last patient has ended participation in a study investigating a precision solution for hypertension.

70
article thumbnail

Curebase and Flow Neuroscience launch clinical trial to test at-home headset for depression

Pharma Times

Device delivers currents to the brain to restore activity usually lowered in depression patients

45
article thumbnail

Fearing the burn: A critical market is on fire

Pharma Manufacturing

The state of the antibiotics market should alarm the world

40
article thumbnail

Accelerator aims to promote digital health innovation in Italy

pharmaphorum

A digital health startup accelerator is launching in Italy, with more than €6 million backing the new enterprise. Called VITA, the accelerator will support up to 10 startups focused on digital transformation of the health system. The project is backed by asset management company CDP Venture Capital SGR, with help from digital health consultancy Healthware Group (pharmaphorum’s parent company) and Danish accelerator Accelerace.

Hospitals 111
article thumbnail

FDA lifts clinical hold on Gilead’s investigational HIV treatment

Outsourcing Pharma

The agency has removed the hold placed on the pharmaceutical companyâs IND for injectable lenacapavir, which is intended for HIV treatment and prevention.

FDA 52
article thumbnail

Sanofi’s Sarclisa combination shows positive results in multiple myeloma patients

Pharma Times

Sarclisa is a monoclonal antibody which targets a specific epitope on the CD38 receptor on multiple myeloma cells

41
article thumbnail

How I Saved My Damaged Hair

The Luxe Pharmacist

I’m honored this post has been so highly requested by you all! My hair’s journey back to health has been a long one and I’m so proud of how far it has come. Please keep in mind my hair has recovered over many years and while many things can help damaged hair it may still take a long time to fully recover. The key is to stop further damage from occurring and make sure your new growth stays happy and healthy.

52
article thumbnail

EU imposes Horizon funding block on UK scientists

pharmaphorum

UK scientists are being denied from joining the €95 billion Horizon research funding programme as a dispute over the trade border in Northern Ireland gets increasingly acrimonious. The UK’s involvement in the Horizon Europe programme as an associate member was included in the Brexit ‘divorce’ deal with EU, but has not been finalised.

105
105
article thumbnail

Trialjectory, foundation to connect blood cancer patients with trials

Outsourcing Pharma

The cancer trial-matching company is partnering with MPN Research Foundation to help match patients with a group of rare blood cancers to clinical trials.

52
article thumbnail

COVID-19 vaccine study focuses on young and immunosuppressed

Pharma Times

Team at Imperial College London will expand MELODY study to include immunosuppressed young people